Darunavir Cobicistat Emtricitabine And Tenofovir Alafenamide + Drugs Competing For Active Tubular Secretion Interaction
Moderateinteraction on record
Description
Co-administration may increase concentrations of emtricitabine and tenofovir, increasing risk of adverse reactions.
Mechanism
Competition for renal tubular secretion or reduced renal function
Source: NLP:darunavir, cobicistat, emtricitabine, and tenofovir alafenamide